Abstract
In Africa, Asia, Latin America, and parts of Oceania, envenoming after snakebite is a serious
public health problem. Conservative data suggest that between 1.2 and 5.5 million people
suffer snakebites every year, resulting in 25,000 to 125,000 deaths and leaving approximately
400,000 victims with permanent sequelae. Despite its significant impact on human health,
this disease remains largely neglected by national and international health authorities, funding
agencies, pharmaceutical companies, patients’ organizations, and health advocacy groups